| Company Name: | PDI, Incorporated | | Ticker Symbol: | PDII | | | WWW Address: | www.pdi-inc.com | | CEO: | Nancy Lurker | | No. of Employees: | 550 | | Common Issue Type: | CS | | Business Description: | A sales and marketing services company, which serves the biopharmaceutical and life sciences industries. Its three segments are: Sales services, Marketing services and Product commercialization.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Business Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 4.17 |  0.08 | 4.06 | 4.23 | 4.11 | 4.19 | 4.09 | 45358 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 59.3 | 14.2 | 0.08 | -2.46 | 0.00 | 0.0 | 0.0 | 6.25 - 2.80 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 4.17 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 59.3 | mil |
| Latest Shares Outstanding | 14.2 | mil |
| Earnings pS (EPS) | -2.46 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 204,596 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 9.0 | mil |
| Float as % of Shares Outstanding | 63.5 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 47.50 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 15.8 | % |
| EBITDA Margin | -31.8 | % |
| Pre-Tax Profit Margin | -36.6 | % |
| Assets Turnover | 0.6 | % |
| Return on Assets (ROA) | -25.6 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -34.4 | % |
| Current Ratio | 4.7 | |
| Leverage Ratio (Assets/Equity) | 1.3 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 5.18 | $ |
| Cash pS | 4.96 | $ |
| Book-Value pS | 6.55 | $ |
| Tangible Book-Value pS | 4.72 | $ |
| Cash Flow pS | -2.04 | $ |
| Free Cash Flow pS | -2.05 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.64 | |
| Price/Tangible Book Ratio | 0.88 | |
| Price/Cash Flow | -2.0 | |
| Price/Free Cash Flow | -2.0 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.0 | 101 | 699 | 447 |
| 4 Weeks | 5.26 | 3.84 | 5.02 | -16.9 | 78 | 486 | 7,779 |
| 13 Weeks | 5.43 | 3.84 | 5.40 | -22.8 | 72 | 258 | 15,480 |
| 26 Weeks | 5.83 | 3.11 | 3.06 | 36.3 | 113 | 254 | 31,548 |
| 52 Weeks | 6.25 | 2.80 | 4.00 | 4.3 | 84 | 253 | 62,694 |
| YTD | 6.25 | 2.80 | - | 4.0 | 85 | 247 | 55,859 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 4.11 | 4.48 | 4.90 | 4.56 | 4.38 | 0.08 | 0.22 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -25.93 | 92.1 | -26.70 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -43.30 | NA | -61.20 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -30.1 | -14.1 | -3.9 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.19 | 0.32 | -1.74 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 54.78 |
| Current Ratio | 3.6 |
| Quick Ratio (Acid Test) | 3.5 |
| Liquidity Ratio (Cash) | 2.88 |
| Receivables Turnover | 5.1 |
| Average Collection Period | 71 |
| Working Capital/Equity | 76.2 |
| Working Capital pS | 5.74 |
| Cash-Flow pS | -2.10 |
| Free Cash-Flow pS | -1.15 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.24 |
| Financial Leverage Ratio (Assets/Equity) | 1.4 |
| Debt Ratio | 28.1 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 9.9 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.38 |
| Tobin's Q Ratio | 0.40 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -0.36 |
| Enterprise Value (EV)/Free Cash Flow | -4.98 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 0.88 |
| Price/Book Ratio - LTM | 0.64 |
| Price/Cash Flow Ratio | -2.0 |
| Price/Free Cash Flow Ratio - LTM | -2.0 |
| Price/Sales Ratio | 0.69 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 2.20 |
| Tangible Book Value pS - LTM | 4.72 |
| Book Value pS - LTM | 6.55 |
| Capital Invested pS | 7.54 |
| Cash pS - LTM | 4.96 |
| Cash Flow pS - LTM | -2.04 |
| Free Cash Flow pS - LTM | -2.05 |
| Earnings pS (EPS) | -2.46 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -14.57 |
| Free Cash Flow Margin 5YEAR AVG | -3.35 |
| Net Profit Margin | -30.6 |
| Net Profit Margin - 5YEAR AVRG. | -2.7 |
| Equity Productivity | 1.05 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.05 |
| Return on Capital Invested (ROCI) | -32.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -4.4 |
| Assets Productivity | 0.70 |
| Return on Assets (ROA) | -23.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | -3.2 |
| Gross Profit Margin | 15.8 |
| Gross Profit Margin - 5YEAR AVRG. | 24.3 |
| EBITDA Margin - LTM | -31.8 |
| EBIT Margin - LTM | -36.6 |
| Pre-Tax Profit Margin | -29.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -1.3 |
| Effective Tax Rate | -2.6 |
| Effective Tax Rate - 5YEAR AVRG. | 1.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 58 |
| Revenue per Employee | 204,596 |
| Net Income per Employee | -62,656 |
| Average Collection Period | 58 |
| Receivables Turnover | 5.1 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 2.04 |
| Assets/Revenue | 1.43 |
| Net Working Capital Turnover | 1.38 |
| Fixed Assets Turnover | 3.12 |
| Total Assets Turnover | 0.7 |
| Revenue per $ Cash | 1.25 |
| Revenue per $ Plant | 20.75 |
| Revenue per $ Common Equity | 1.05 |
| Revenue per $ Capital Invested | 1.05 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 35.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 24.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |